review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Yuekang Xu | |
Mengting Zi | |||
P2860 | cites work | Cystatin C deficiency in human atherosclerosis and aortic aneurysms | Q22010733 |
The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases | Q24317192 | ||
Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion | Q24338550 | ||
Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer | Q24648403 | ||
Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping | Q27630854 | ||
Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily | Q27634658 | ||
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases | Q27636471 | ||
TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression | Q28252494 | ||
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation | Q28263551 | ||
Immunolocalization of human cystatins in neutrophils and lymphocytes | Q28268283 | ||
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis | Q28289614 | ||
Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S | Q28306406 | ||
Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum | Q28366558 | ||
A null mutation in the cystatin M/E gene of ichq mice causes juvenile lethality and defects in epidermal cornification | Q28591093 | ||
Macrophage responses to interferon-gamma are dependent on cystatin C levels | Q47790588 | ||
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis | Q47812668 | ||
Epidermal SH-protease inhibitor in human neoplasms and their metastases | Q47857795 | ||
Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. | Q47872621 | ||
Folding-related dimerization of human cystatin C. | Q49161781 | ||
Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. | Q52049353 | ||
A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. | Q53558760 | ||
Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. | Q54126242 | ||
α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling | Q56999751 | ||
Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor | Q59067412 | ||
Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies | Q61647750 | ||
Degradation of cartilage matrix components by the cysteine proteinases, cathepsins B and L | Q67874363 | ||
Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis | Q68061622 | ||
Rat cystatin C: inhibitor of granulocyte phagocytic functions | Q68477587 | ||
Tissue and biological fluid distribution of cysteine proteinases inhibitor: rat cystatin C | Q68920149 | ||
Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells | Q70082362 | ||
Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I | Q70550452 | ||
Degradation of bone matrix proteins by osteoclast cathepsins | Q70647581 | ||
Identification of acid cysteine proteinase inhibitor (cystatin A) in the human thymus | Q71666352 | ||
Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages | Q71763125 | ||
Ficin and papain inhibitor from chicken egg white | Q72044085 | ||
Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymph node germinal centres | Q72561286 | ||
Impairment of function in aging neutrophils is associated with apoptosis | Q72972559 | ||
Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis | Q73231469 | ||
Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium | Q73715362 | ||
Production of fully active recombinant murine granzyme B in yeast | Q74047923 | ||
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration | Q74513012 | ||
Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice | Q74595052 | ||
Activation of caspase-3-like protease by digitonin-treated lysosomes | Q77378023 | ||
Germinal center B cell apoptosis requires both caspase and cathepsin activity | Q78145140 | ||
Leishmania cysteine proteinases: virulence factors in quest of a function | Q79239741 | ||
Proteomics identifies enhanced expression of stefin A in neonatal murine skin compared with adults: functional implications | Q80176152 | ||
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties | Q80435897 | ||
IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells | Q81476292 | ||
Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study | Q86579290 | ||
Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator | Q87131157 | ||
The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling | Q31838704 | ||
Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells. | Q32128435 | ||
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response | Q32133512 | ||
Regulation of pro-apoptotic leucocyte granule serine proteinases by intracellular serpins. | Q33547789 | ||
Analysis of genes expressed at the infective larval stage validates utility of Litomosoides sigmodontis as a murine model for filarial vaccine development | Q33600663 | ||
Molecular cloning and characterization of cystatin, a cysteine protease inhibitor, from Angiostrongylus cantonensis | Q33612432 | ||
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity. | Q33772507 | ||
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression | Q33936542 | ||
Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis | Q34243287 | ||
Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. | Q34307920 | ||
Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting | Q34328593 | ||
Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages | Q34385281 | ||
The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics | Q34416331 | ||
Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c | Q34457741 | ||
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis | Q34603580 | ||
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators | Q34754105 | ||
Immunomodulatory properties of cystatins | Q35003239 | ||
Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. | Q35148879 | ||
Modulation of host immune responses by nematode cystatins | Q35295296 | ||
Cystatins--inhibitors of cysteine proteinases | Q35361416 | ||
Interleukin-10. | Q35453751 | ||
Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo | Q35558255 | ||
Harlequin ichthyosis (ichq): a juvenile lethal mouse mutation with ichthyosiform dermatitis | Q35763692 | ||
Dendritic cell maturation and antigen presentation in the absence of invariant chain. | Q35789511 | ||
Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor. | Q35889004 | ||
How to induce involuntary suicide: the need for dipeptidyl peptidase I. | Q35992269 | ||
Epidermal differentiation: the role of proteases and their inhibitors | Q36023293 | ||
Towards novel anti-cancer strategies based on cystatin function | Q36127269 | ||
Antigen processing and presentation by dendritic cells: cell biological mechanisms | Q36148922 | ||
Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation | Q36354300 | ||
Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani | Q36367801 | ||
Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion | Q36370419 | ||
Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation | Q36376590 | ||
Role of Enzyme Receptors and Inhibitors in Regulating Proteolytic Activities of Macrophages | Q36398647 | ||
New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. | Q36525095 | ||
The influence of uremic high cystatin C concentration on neutrophil apoptosis and selected neutrophil functions isolated from healthy subjects | Q36576986 | ||
Role of nitric oxide in parasitic infections | Q36670368 | ||
Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes | Q36704066 | ||
Inhibitory effects of recombinant human cystatin C on human coronaviruses | Q36757299 | ||
Cystatin C: current position and future prospects | Q37313436 | ||
Proteases and bone remodelling | Q37337224 | ||
A central role of perforin in cytolysis? | Q37357813 | ||
Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system. | Q37683390 | ||
Cystatins of parasitic organisms | Q37887599 | ||
Cystatins in immune system | Q38079586 | ||
Human dendritic cell functional specialization in steady-state and inflammation. | Q38205437 | ||
Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide | Q38318972 | ||
Cystatin C is a disease-associated protein subject to multiple regulation | Q38341202 | ||
The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes | Q38865942 | ||
A filarial cysteine protease inhibitor down-regulates T cell proliferation and enhances interleukin-10 production | Q39051585 | ||
Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes | Q39158481 | ||
Cystatin C induces apoptosis and tyrosine hydroxylase gene expression through JNK-dependent pathway in neuronal cells | Q39556201 | ||
IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression. | Q39596407 | ||
Parasite-Specific Immunomodulatory Functions of Filarial Cystatin | Q39746044 | ||
Psoriasis is associated with increased beta-defensin genomic copy number | Q39789019 | ||
Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways | Q39886821 | ||
Upregulation of the release of granulocyte-macrophage colony-stimulating factor from keratinocytes stimulated with cysteine protease activity of recombinant major mite allergens, Der f 1 and Der p 1. | Q40034245 | ||
Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases | Q40403173 | ||
T-cell activation: integration of signals from the antigen receptor and costimulatory molecules | Q40422805 | ||
Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells | Q40435440 | ||
Involvement of TNF and NF-kappa B in the transcriptional control of cyclooxygenase-2 expression by IFN-gamma in macrophages. | Q40455065 | ||
Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. | Q40812914 | ||
Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity | Q40992862 | ||
Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. | Q41005582 | ||
Expression of human recombinant granzyme A zymogen and its activation by the cysteine proteinase cathepsin C. | Q41205122 | ||
A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation. | Q41544835 | ||
Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation. | Q41601445 | ||
Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity | Q41779335 | ||
Cystatin C influences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development | Q41911555 | ||
Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones | Q42070272 | ||
CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis | Q43145952 | ||
Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase | Q43670726 | ||
Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus | Q43729125 | ||
Cystatins of filarial nematodes up-regulate the nitric oxide production of interferon-gamma-activated murine macrophages | Q44024607 | ||
Upregulation of cystatin C expression in the rat hippocampus during epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. | Q44066411 | ||
Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders | Q44390242 | ||
The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. | Q44649101 | ||
alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression | Q45063959 | ||
Identification of salivary proteins inhibiting herpes simplex virus 1 replication | Q45787575 | ||
Modelling and simulating interleukin-10 production and regulation by macrophages after stimulation with an immunomodulator of parasitic nematodes. | Q46003934 | ||
P304 | page(s) | 80-90 | |
P577 | publication date | 2018-01-31 | |
2018-04-01 | |||
P1433 | published in | immunology Letters | Q15766068 |
P1476 | title | Involvement of cystatin C in immunity and apoptosis | |
P478 | volume | 196 |
Q98779141 | Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation |
Q96641020 | Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms |
Q91174495 | Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease |
Q64114621 | Immunosuppressive effects of tick protein RHcyst-1 on murine bone marrow-derived dendritic cells |
Search more.